Fennec Pharmaceuticals shares owned by Jpmorgan Chase & Co
Quarter-by-quarter ownership of Fennec Pharmaceuticals (FENC) shares owned by Jpmorgan Chase & Co
from 13F filings
Historical chart of Jpmorgan Chase & Co investment in Fennec Pharmaceuticals
Tip: Access up to 7 years of quarterly data
All positions including Fennec Pharmaceuticals held by Jpmorgan Chase & Co consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Fennec Pharmaceuticals by Jpmorgan Chase & Co
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-03-31 | $109k | 9.8k | 11.12 |
| 2023-12-31 | $147k | 13k | 11.21 |
| 2023-09-30 | $89k | 12k | 7.51 |
| 2023-06-30 | $128k | 15k | 8.83 |
| 2023-03-31 | $999 | 70 | 14.29 |
| 2022-12-31 | $999 | 70 | 14.29 |
| 2022-06-30 | $69k | 7.7k | 8.87 |
| 2022-03-31 | $91k | 16k | 5.58 |
| 2021-12-31 | $0 | 70 | 0.00 |
| 2021-03-31 | $142k | 23k | 6.18 |
| 2020-12-31 | $72k | 9.7k | 7.47 |
| 2020-09-30 | $48k | 8.0k | 6.02 |
| 2020-06-30 | $61k | 7.3k | 8.40 |
| 2019-09-30 | $999 | 110 | 9.09 |
| 2019-03-31 | $14k | 2.8k | 4.95 |
| 2018-12-31 | $22k | 3.6k | 5.97 |
| 2018-09-30 | $22k | 2.7k | 8.19 |
| 2018-06-30 | $398k | 38k | 10.43 |